News and Views
Nature Medicine 15, 244 - 246 (2009)
doi:10.1038/nm0309-244
Choosing the right memory T cell for HIV
Genoveffa Franchini1
- Genoveffa Franchini is in the Animal Models and Retroviral Vaccines Section, US National Cancer Institute, Building 41 Room D-804, Bethesda, Maryland 20892-5065, USA. e-mail: franchig@mail.nih.gov
Abstract
An experimental simian immunodeficiency virus vaccine boosts production of memory T cells at the site where the virus first contacts the body—in the mucosa (pages 293–299). The approach has the potential to result in more effective HIV vaccines than those currently under development.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Progress towards a vaccine to prevent sexual transmission of HIVNature Medicine News and Views (01 Jul 1996)
RESEARCH
High Accuracy of Narrow Band Imaging Without Magnification for the Real-Time Characterization of Polyp Histology and Its Comparison With High-Definition White Light Colonoscopy: A Prospective StudyThe American Journal of Gastroenterology Article Response
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challengeNature Medicine Letter (01 Mar 2009)
Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeysMucosal Immunology Article Response
